UBC PiMS Research Group
Pharmacoepidemiology in Multiple Sclerosis Research Group

Jose Wijnands

Dr. Jose Wijnands

Jose WijnandsPrevious Academic Training: PhD in Health Sciences, MSc in Public Health, BSc in Health Sciences (Maastricht University, the Netherlands)

Supervisor: Helen Tremlett, PhD

Project: The PrOMS study: explore and establish the existence of symptomatic prodromal phase(s) in MS

 

Awards:

MS Society of Canada endMS Scholar Program for Researchers IN Training (SPRINT) Trainee (2016-2017)

MS Society of Canada endMS Summer School Travel and Training Award (2015)

The Dutch Arthritis Foundation travel award to attend the Annual meeting of the American College of Rheumatology (ACR), San Diego, America, October 25-30, 2013

The European League Against Rheumatism (EULAR) travel award to attend the Annual meeting of the EULAR, Madrid, Spain, June 12-15, 2013

 

Publications:

Wijnands JMA, Kingwell E. Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis [Editorial]. Journal of Neurology, Neurosurgery & Psychiatry. 2016; 87:453.

Wijnands JMA, Van Durme C, Driessen JHM, Boonen A, Klop C, Leufkens B, Cooper C, Stehouwer CDA, de Vries F. Individuals with type 2 diabetes mellitus are at an increased risk of gout but this is not due to diabetes: a population-based cohort study. Medicine. 2015; 94:e1358

Wijnands JMA, Boonen A, van Sloten TT, Schram MT, Sep SJS, Koster A, van der Kallen CJH, Henry RMA, Dagnelie PC, Stehouwer CDA, van der Linden S, Arts ICW. The association between uric acid, aortic, carotid, and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study. Journal of Hypertension. 2015; 33:1642-1650

 Wijnands JMA, Houben AJHM, Muris D, Boonen A, Schram M, Sep SJS, van der Kallen CJH, Henry RMA, Dagnelie PC, van der Linden S, Schaper NC, Arts ICW, Stehouwer CDA. Uric acid and skin microvascular function: The Maastricht Study. Journal of Hypertension. 2015; 33:1651-1657

Spaetgens B, Wijnands JMA, van Durme van der Linden S, C, Boonen A. Content and construct validity of The Rheumatic Diseases Comorbidity Index in patients with gout. Rheumatology. 2015; 54:1659-1663

Spaetgens B, Tranduy A, Wijnands JMA, van der Linden S, Boonen A. Health and utilities in patients with gout under care of a rheumatologist: Which factors contribute? Arthritis Care and Research. 2015; 67:1128-1136

Spaetgens B, Wijnands JMA, van Durme C, van der Linden S, Boonen A. Cost of illness and determinants of costs among patients with gout. Journal of Rheumatology. 2015; 42:335-344

 Wijnands JMA, Viechtbauer W, Thevissen K, van der Linden S, Dagnelie PC, Stehouwer CD, Arts ICW, Boonen A. Determinants of the prevalence of gout in the general population: systematic review and meta-regression. European Journal of Epidemiology. 2015; 30:19-33

 Wijnands JMA, Boonen A, Dagnelie PC, van Greevenbroek MMJ, van der Kallen, CJH, Ferreira I, Schalkwijk CG, Feskens AJM, Stehouwer CDA, van der Linden S, Arts ICW. The cross-sectional association between uric acid and atherosclerosis, and the role of low-grade inflammation: the CODAM study. Rheumatology. 2014; 53:2053-2062

 Wijnands JMA, Boonen A, Arts IC, Dagnelie PC, Stehouwer CD, van der Linden S. Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria. Current Rheumatology Reports. 2011; 13:167-174

 

Dissertation: 

Wijnands JMA. Gout, uric acid and cardiovascular disease: know your enemy. Maastricht University, Maastricht, the Netherlands. 2014. Supervisors: A Boonen, ICW Arts, CDA Stehouwer.

 

Conference abstracts:

Wijnands JMA, Hoegg T, Zhu F,  Kingwell E, Zhao Y, Fisk JD, Evans C, Ekuma O, Carruthers RL, Marrie RA, Tremlett H. Risk of infection-related hospitalizations in people with primary-progressive relative to relapsing-onset multiple sclerosis. Neurology 2016; 86 (Suppl P3.353) [Presented at the American Academy of Neurology Annual Meeting, April 2016, Vancouver, Canada]

Wijnands JMA, Viechtbauer W, Thevissen K, Arts ICW, Dagnelie PC, Stehouwer CDA, van der Linden S, Boonen A. Insufficient evidence for an increase in prevalence of gout: A systematic review and meta-regression analysis. Arthritis & Rheumatism 2013; 65 (Suppl 10): 90 [presented at the Annual meeting of the American College of Rheumatology (ACR), October 2013, San Diego, USA]

Wijnands JMA, Boonen A, Dagnelie PC, van Greevenbroek MMJ, van der Kallen, CJH, Ferreira I, Schalkwijk CG, Feskens AJM, Stehouwer CDA, van der Linden S, Arts ICW. The role of low-grade inflammation in the association between uric acid and atherosclerosis: the CODAM study. Arthritis & Rheumatism 2013; 65 (Suppl 10): 1724 [presented at the Annual meeting of the American College of Rheumatology (ACR), October 2013, San Diego, USA]

Wijnands JMA, Viechtbauer W, Thevissen K, Arts ICW, Dagnelie PC, Stehouwer CDA, van der Linden S, Boonen A. The prevalence of gout is highly influenced by the applied classification criteria: results of a systematic review and meta-regression analysis of the literature. Annals of Rheumatic Diseases 2013;72(Suppl 3):710 [presented at the Annual meeting of The European League Against Rheumatism, June 2013, Madrid, Spain]

 

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia